Genetic neurodevelopmental disorders that often include epilepsy as part of their phenotype are a heterogeneous and clinically challenging spectrum of disorders in children. Although seizures often contribute significantly to morbidity in these affected populations, the mechanisms of epileptogenesis in these conditions remain poorly understood. Different model systems have been developed to aid unraveling these mechanisms, which include a number of specific mutant mouse lines which genocopy specific general types of mutations present in patients. These mouse models have not only allowed assessments of behavioral and electrographic seizure phenotypes to be ascertained, but also have allowed effects on the neurodevelopmental alterations and cognitive impairments associated with these disorders to be examined. In addition, these models play a role in advancing our understanding of these epileptic processes and developing preclinical therapeutics. The concordance of seizure phenotypes -in a select group of rare, genetic, neurodevelopmental disorders and epileptic encephalopathies -found between human patients and their model counterparts will be summarized. This review aims to assess whether models of Rett syndrome, CDKL5 deficiency disorder, Fragile-X syndrome, Dravet syndrome, and Ohtahara syndrome phenocopy the seizures seen in human patients.
and Ohtahara 34 syndrome (Beal et al., 2012) . Patients with any of these 35 rare conditions often do not display a single or even com-36 mon types of seizures, however, but rather can display a 37 multitude of different seizure types that include focal, 38 multi-focal, or generalized seizures (Crino et al., 2002;  39 Glaze et al., 1998; Kato et al., 2007; Musumeci et al., 40 1999 Wither et al., 2018) . 148 In addition to this absence-like seizure phenotype, 149 however, an additional type of seizure has been noted 150 in mostly female MeCP2-heterozygous mice. Although 151 much less studied than the absence-like activity 152 highlighted above, these seizures are associated with 153 behavioral (i.e. not captured on EEG to verify that they 154 are truly epileptic) tonic or status-like convulsive activity, 155 and often occur immediately following handling or cage- houses an R168X Mecp2 nonsense mutation (Schaevitz 161 et al., 2013) . This nonsense mutation may be functionally 162 null, however, as truncated MeCP2 protein was not 163 detected in an independently generated R168X mouse 164 line (Mecp2 R168XHuppke ), which was not specifically 165 assessed itself for epileptiform discharge activity 166 (Brendel et al., 2011) . 167 In addition to these MeCP2-null allele models, 168 spontaneous bilateral cortical discharges and myoclonic 169 jerks have also been observed in male Mecp2 tm1Hzo mice, which express a MeCP2 protein truncated at 171 position 308 (Shahbazian et al., 2002) (Fig. 1 ). In these 172 mice, discharge activity is progressive, and only became 173 overtly evident after about 6 months of age (Shahbazian 174 et al., 2002 In addition to these models, several other cell-type 188 selective Mecp2 ablation models also exist that have 189 allowed better identification of the excitatory and 190 inhibitory circuitries underlying the observed seizure 191 phenotypes. These models will not be expanded upon 192 here for brevity, but are discussed in detail elsewhere 193 (Eubanks, 2017; Katz et al., 2012) . 194 Seizure correlations between RTT (Kalscheuer et al., 2003; Scala et al., 2005; Tao et al., 252 2004; Weaving et al., 2004) , and like RTT patients often 253 display hypotonia, stereotypy, and loss of speech 254 (Kalscheuer et al., 2003) . For Gabar a 1, mice that lack functional a1 subunits 612 have been generated (Vicini et al., 2001 durations of 1.5-2 s (Fig. 7) , which were partially sup-731 pressed by leviteracetam (Kovacˇevic´et al., 2018) . In addition to the Arx KO and missense mutation mice, 790 different groups have also generated mutant mice that 791 house poly-alanine expansions within the ARX coding 
